Currently, my research focuses on the development of bile acid analogues inhibitory to Clostridium difficile spore germination. I am also interested in developing new reaction strategies for novel heterocycles of potential therapeutic properties. Most of my research efforts have been focused on developing modulators for Sirtuin enzyme for the post-translational modification studies.
Post-Doctoral Research Associate
Carnegie Mellon University - Department of Chemistry- Center for DNA Science and Technology (CNAST), Pittsburgh, PA, USA
“Development of Janus-based γ-peptide nucleic acids (J-γPNAs) for targeting unstable CUG-RNA repeats towards the treatment of muscular dystrophy”.
Organic & Medicinal Chemistry – Dr. Reddy’s Institute of Life Sciences, University of Hyderabad, India.
- Ali Nakhi, Md. S. Rahman, G. P. K. Seerapu, B. Rakesh Kumar, K. L. Kumar, Pushkar Kulkarni, D. Haldar, Manojit Pal. Transition metal free hydrolysis/cyclization strategy in a single pot: Synthesis of fused furo N-heterocycles of pharmacological interest. Org. Biomol. Chem. 2013, 11, 4930. Most Read Article
Ali Nakhi, S. Archana, G. P. K. Seerapu, Ch. Keerthana Sarma, K. Lalith Kumar, Pushkar Kulkarni, Devyani Haldar, Manojit Pal. AlCl3 mediated hydroarylation–heteroarylation in a single pot: a direct access to densely functionalized olefins of pharmacological interest. Chem. Commun. 2013, 49, 6268.
Ali Nakhi, Bagineni Prasad, Raja Mohan Rao, Uppender Reddy, Sandhya Sandra, Ravada Kishore, Javed Iqbal, Manojit Pal. A new route to indoles via Sila-Sonogashira strategy: Identification of novel small molecules as potential antituberculosis agents. Med. Chem. Commun. 2011, 2, 1006.
Ali Nakhi, Raju Adepu, D. Rambabu, Ravada Kishore, G. R. Vanaja, Arunasree M. Kalle, Manojit Pal. Thieno[3,2-c]pyran-4-one based novel small molecules: their synthesis, crystal structure analysis and in vitro evaluation as potential anticancer agents. Bioorg.Med. Chem. Lett. 2012, 22, 4418.